In future studies, our research group will further examine the role of KLF14 and discern its underlying mechanisms of action in various oncological behaviors in cervical cancer, thereby providing a novel foundation for the development of therapeutic drug targets of KLF14. The gene discussed is KLF14; the disease is cervical carcinoma.